Deals
23andMe Raises More Than $80 Million in Equity Financing Round
A 23andMe Inc. DNA genetic test kit.
Photographer: Cayce Clifford/BloombergThis article is for subscribers only.
DNA testing company 23andMe Inc. raised more than $80 million in equity in a financing round led by Sequoia Capital and NewView Capital.
According to Securities and Exchanges Commission filings, the company offered $85 million in equity and sold about $82.5 million. Previously, the company had raised about $791 million. The Series F financing will be used for general corporate purposes, spokesman Andy Kill said.